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In its simplest terms, obesity is a disease of inappropriate food intake.  While 
current treatment of obesity focuses on changing behavior, few successful 
models of behavior modification have been developed.  Even those treatments 
that are successful in the short-term, have failed to demonstrate lasting effect.  
The problem of over-eating, then, needs to be studied in terms of basic 
motivational programs that are encoded by the brain’s reward system. 
Understanding the way in which reward system activity directs eating behavior 
will allow more sophisticated and efficacious treatment options in the future. 
Several studies have focused on the nucleus accumbens (NAc) as an important 
regulator of motivation and reward seeking.   There are two primary populations 
of neurons in the NAc at work in modulating motivation and reward-related effort.  
Several studies have given insight into what each of these may be doing to direct 
food intake.  The present study expands on this body of knowledge using a novel 
technique to accomplish cell-type-specific assessment of neural activity during 
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1.  Obesity and Eating: Clinical Treatment and Scientific Understanding 
Food and nutrition are increasingly recognized as primary determinants of 
health and disease.  While proper nutrition is essential to normal growth and 
development, over-consumption of calorie-dense foods high in simple 
carbohydrates, salt and saturated fat cause diseases like hypertension, diabetes 
and obesity (associated with these and multiple other health problems). 
Dramatically increased rates of obesity in the United States (from 15% adults in 
1990 to 35% adults in 2014) has prompted study of the pathophysiology of 
weight gain from several disciplinary perspectives.  From an economic standpoint, 
the social and medical impacts of obesity are significant.  In 2008, the estimated 
medical cost of obesity-related dysfunction was $147 billion dollars, and persons 
with obesity incur 42% higher medical costs than average (Finkelstein, Trogdon, 
Cohen, & Dietz, 2009).  It is fair, then, to call rising rates of obesity a healthcare 
crisis that needs new tools to address treatment and prevention.  While genetic, 
metabolic, hormonal and immune system dysfunction are all associated with 
obesity, in its simplest terms, obesity results from energy imbalance: too much 
intake and too little expenditure.   
Logically, behavior modification is first-line treatment for overweight and 
obesity.  Despite such therapy, patients often fail to achieve lasting change or 
avoid negative health consequences of these disorders.  Reasons that behavior 
modification fails are myriad.  As patients revert to problematic habits, it becomes 
clear that effective behavioral strategies require a better understanding of the 
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motivational drives and decision-making processes involved in food choice and 
food intake.  An emerging field in molecular psychiatry provides a new 
perspective on eating behavior that focuses on the effect of food on the reward 
system and gives insight to new avenues for behavioral and pharmacologic 
treatment of disordered eating.  A review of current treatment practices 
underscores the need for further research into the role of the brain’s reward 
circuit in directing eating behaviors.   
 
1.1 Treatment Approaches for Obesity  
1.1.1 Lifestyle Modification 
In the primary care clinic, lifestyle modification is first-line treatment for 
overweight and obesity.  Obesity is defined by Body Mass Index (BMI) greater 
than 30 (BMI is an index that uses height, weight and sex to quantify body fat 
tissue).  This is not a perfect measure, however it is widely accepted and used to 
stratify patients.  BMI of 19-25 is classified as normal, and BMI 25-30 is classified 
as overweight). The current standard of care in obesity treatment is first to enact 
a behavioral therapy program.  Intensive behavioral therapy is most effective 
(Tate & Wing, 2000; Wadden & Butryn, 2003; Wadden, McGuckin, Rothman, & 
Sargent, 2003) and is generally carried out over a period of 6-12 months.  Most 
programs start with weekly sessions for the first 4-6 weeks, followed by gradual 
spacing out of sessions from bi-weekly, to monthly.  Long-term follow-up intervals 
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vary between programs but have demonstrated effectiveness up to 2 years.  In 
general, models for behavioral interventions aim to reduce daily caloric intake 
and increase daily exercise using a cadre of behavioral and cognitive techniques 
to help patients maintain healthy habits (Berkel, Poston, Reeves, & Foreyt, 2005; 
Carvajal, Wadden, Tsai, Peck, & Moran, 2013).   Calorie restriction diets are 
usually modest, 1200 kcal/day for women, and 1500 for men.  Patients are given 
healthy food options and advised to avoid calorie-dense, high-sugar and high-fat, 
food sources (Berkel et al., 2005; Fabricatore & Wadden, 2006).  There is no 
consensus on recommendations for how to balance macronutrients (i.e. fat, 
protein, carbohydrates) at each meal and throughout the day.  Exercise goals are 
set at 30 minutes of moderate cardiovascular challenge per day (e.g. walking 4.0 
mph).  Patients will hopefully achieve excess calorie burn of about 1000 kcals per 
week.  Several studies have demonstrated success using behavioral modification 
with most patients achieving 5-10% weight loss (Fabricatore et al., 2011).  While 
this degree of weight loss may not normalize BMI, in 2003, a landmark study the 
Look AHEAD trial, demonstrated that even a 7% weight loss has clinically 
significant benefits on cardiovascular health and glucose tolerance (Ryan et al., 
2003).  Therefore, intensive behavioral programs are largely seen as a low-cost 
intervention to achieve clinically meaningful weight loss. 
In 2011, these promising data prompted the Centers of Medicare and 
Medicaid Services (CMS) to begin covering intensive behavioral therapy for 
treatment of obesity in primary care (Services, 2011).   However, the model 
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supported by the CMS differs significantly from those that have been studied.  
First, the CMS mandates that therapy be completed by primary care providers in 
the clinic rather than by specialized therapists.  Second, although their model 
covers the same number of visits as most successful intensive therapy programs, 
CMS limits session time to 10-15 minutes rather than 60-90 minute sessions 
endorsed by successful weight loss programs (Force, 2003; Pagoto, 2012).  
These differences in implementation have caused significant concern among 
primary care providers who often lack training in behavioral therapy.  A year after 
the CMS policy change, the Society of Behavioral Medicine published its own 
policy brief commending the CMS decision to support behavioral therapy but 
noting “concern about the degree to which it can be feasibly implemented in its 
current form given the limitations in providers who are covered and the length of 
counseling visits being significantly shorter than in evidence-based protocols” 
(Pagoto, 2012).  In addition, the intensive therapy schedule dramatically 
increases the time burden on already under-resourced clinics. Not surprisingly, 
preliminary evaluations of primary care-based interventions have demonstrated 
limited efficacy.  A review of several primary care-based interventional models 
found an average weight loss of just 1-3 kg in 6-24 months of intervention 
(Carvajal et al., 2013).  Success has been limited by infrequent and brief 
interactions between patient and caregivers, which are inadequate for 
establishing the momentum needed for meaningful change but may be all that 
can be achieved in busy primary care practices.  A second limitation is that 
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sessions are not carried out by personnel trained in behavioral therapy—an 
essential feature of successful programs.  More time is needed to fully assess the 
successes and constraints of the primary care model of obesity intervention.  
With this backdrop, what is most concerning about the treatment of obesity in 
both the primary care and intensive behavioral program settings is that long-term 
adherence to weight loss strategies is incredibly poor.  Weight gain and relapse 
are almost inevitable.   
Long-term follow-up of individuals who have successfully lost 10% of initial 
body weight shows that 80% have regained weight at one year (Wing & Phelan, 
2005). Even in the most successful programs in which significant weight loss is 
achieved by most participants early on, as frequency and intensity of therapy 
declines, weight loss stops and the pounds gradually come back.  Extended 
therapy augmented by telephone calls text or email check-ins can delay weight 
regain (Appel et al., 2011; Ely et al., 2008; Perri, 2014).  Still, few patients can 
maintain weight loss for the 2-4 year benchmark that is associated with long-term 
successful weight management (Wing & Phelan, 2005). 
1.1.2 Bariatric Surgery 
Failures in primary care and behavioral management of obesity have led to 
an increase in popularity and necessity of bariatric surgery.  Because of the 
general risk associated with surgery (amplified by obesity), bariatric surgery is 
reserved for patients with BMI > 40 or > 35 with a significant medical co-morbidity.  
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There are several surgical procedures for weight loss, which have an overall 90% 
success rate defined by excess weight reduction of > 50% in the first year 
(Spivak, Abdelmelek, Beltran, Ng, & Kitahama, 2012). Achieving this weight loss 
with behavioral therapy alone seems only possible with inpatient programs as 
seen on television shows like “The Biggest Loser,” in which participants are 
sequestered and placed on strict diet and exercise schedule as well as given 
group therapy for a period of weeks-months.  Thus, bariatric surgery is currently 
the best treatment option for excess weight loss and resolution of metabolic 
syndrome in obese subjects who require greater than 5-10% weight reduction.  
Still, surgery does not eliminate the need for behavior therapy.  Long-term 
success in these patients requires lasting lifestyle changes.  The field of bariatric 
surgery has been very conscientious about mandating that patients demonstrate 
an ability to lose weight through lifestyle changes before surgery.  However, 
surgeons have the same faulty behavioral intervention tools as primary care 
physicians.   
This point is underscored by studies of long-term health outcomes of patients 
who have undergone Roux-en-Y gastric bypass (RYGB)—the most effective 
bariatric surgery.  One study reviewed 10-year outcomes for 1,402 RYGB 
patients and found that at 18 months, patients reached a nadir in weight loss.  At 
this point post-surgery, patients achieved 79% excess weight loss (EWL), and 
average BMI was reduced from 47 to 30.  However, patients subsequently 
regained weight and at 12 years post-surgery, patients rebounded to 53% EWL 
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compared to pre-surgery body weight and average BMI was 37.  In addition, at 
10 years, there was a 19% recurrence in diabetes (Kothari, Borgert, Kallies, 
Baker, & Grover, 2016). 
Weight regain after bariatric surgery is an issue gaining attention.  Due to the 
high-initial cost and risk of this obesity treatment, surgery is only cost-effective if 
patients maintain weight loss and associated health gains in the long-term.  Up to 
60% of gastric-band patients experience weight regain (Magro et al., 2008).  
Factors associated with post-surgical regain include insufficient lifestyle 
modification and inadequate treatment of underlying eating disorders that 
contribute to obesity.  Although immediately after surgery, most patients 
experience a decrease in appetite and food cravings, these return over time and 
patients may be ill-equipped to control their eating behaviors (Maleckas, 
Gudaityte, Petereit, Venclauskas, & Velickiene, 2016). 
1.1.3 Cognitive Behavioral Therapy  
One theory about the lack of lasting success of behavioral therapy is that 
these interventions do not adequately address cognitive control mechanisms 
involved in making decisions around food.  In 2010, Cooper et al posited that 
long-term failures in weight loss maintenance might be mitigated by employing 
cognitive behavioral therapy (CBT) aimed to increase patients’ awareness of 
cognitive processes that hinder weight loss (e.g. stress, despair, unrealistic 
expectations).  To investigate this idea, they conducted a 3-year longitudinal 
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study in which participants were assigned to receive traditional behavioral 
therapy (BT) or CBT.  At the end of the study, the authors found that CBT had no 
effect on long-term weight loss when compared to traditional BT, and in fact, at 
three years, patients in both groups had regained almost all the weight lost during 
initial therapy.  However, CBT did significantly improve patient’s self-perception 
and reduce negative psychiatric symptoms (Cooper et al., 2010).  It seems, then, 
that behavioral change is not simply a matter of lack of education or cognitive 
tools to deal with pathological eating.   
 
1.2 Food Addiction 
Perhaps, a useful shift in perspective would reframe understanding of the 
primary dysfunctions involved in over-eating.  Rather than focus on effort to exert 
greater executive control over food intake, we might think about ways in which 
foods can derail cognitive control systems.  In other words, certain foods may 
have the capacity to alter an individual’s neural circuitry in such a way that 
cognitive control is no longer feasible.  In such cases, these foods will have 
become addictive, and patients may now require specialized intervention that 
targets foods as substances of abuse.   
1.2.1 Validating Food Addiction 
A growing body of research has demonstrated parallels between effects of 
drugs of abuse and certain foods that are high in sugar and/or fat on addiction-
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like behavior.  According to the DSM-IV-TR, there are seven features of behavior 
that constitute addiction.  Several of these can be modeled in animals fed high-fat 
or high-sugar diets.  Most prominent behaviors include overuse, tolerance, 
compulsive intake, and even withdrawal.  In 2008 Avena et al. provided 
convincing evidence that animals given intermittent access to sugar developed a 
“sugar addiction” phenotype in which animals displayed bingeing behaviors, as 
well as evidence of withdrawal, craving, cross-sensitization and gateway effect in 
which animals are more vulnerable to excessive alcohol intake when remaining 
abstinent from sugar (Avena, Rada, & Hoebel, 2008).   
Research on the similarities between addiction and overeating has led to the 
question of whether people can suffer from “food addiction.”  Work by Ashley 
Gearheardt at Yale opened this field of study with the development of the Yale 
Food Addiction Scale in 2009.  Prior to the development of this scale the idea of 
food addiction had been studied based on self-diagnosis and varying definitions.  
The YFAS has now been validated in several studies with varying populations. 
These studies have demonstrated that food addiction does, in fact, exist in both 
normal weight and overweight subjects (Gearhardt, Corbin, & Brownell, 2009).  
However, in one study, having a food addiction was associated with a 3.5 fold 
higher risk of being overweight or obese (Pedram et al., 2013).  In addition, 
subjects with food addiction have a higher rate of failed weight loss in both 
behavioral therapy and surgical populations (Davis et al., 2011).   
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This research may highlight a useful clinical tool for stratification and 
identification of obese patients who will require specific strategies to combat their 
addiction in contrast to similarly obese patients for whom food is not an addiction.  
A number of studies have suggested that 15% of patients needing behavioral 
treatment and 40% of patients seeking bariatric surgery for obesity met criteria 
for food addiction (Eichen, Lent, Goldbacher, & Foster, 2013; Meule, Heckel, & 
Kubler, 2012). Equally important, describing some foods as addictive reframes 
scientific understanding of control over food intake and shifts investigation toward 
the ways in which food affects the brain’s reward system.  Such investigations 
can take advantage of a large existing literature on addiction.   
1.2.2 Shared Neural Circuitry Between Food and Drugs of Abuse  
The overlap between brain effects of drugs of abuse and over-eating have 
been demonstrated at the cellular level via shared changes in neuronal circuitry, 
as well as at the behavioral level in evidence from human imaging and survey 
studies. In 2007, the National Institute of Drug Abuse (NIDA) joined the NIH 
obesity task force to support research on the addictive properties of food.  
According to NIDA director Nora Volkow, “This research opens the door for us to 
apply some of the knowledge we have gathered about drug addiction to the study 
of overeating and obesity.”  That there are so many similarities between over-
eating and addiction is not surprising.  One of the principles of our understanding 
of drugs of abuse is that we are susceptible to these compounds because they 
manipulate the “pleasure” centers in the brain which have evolved to reinforce 
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behaviors that are good for us such as eating and sex.  These behaviors release 
dopamine (DA) and trigger a series of neuroadaptations.   
Dopamine is a key neurotransmitter in the limbic, or affective, systems of the 
brain.  While this chemical has several complex functions, it is best known for its 
roles in movement disorders (such as Parkinson’s disease) and reward signaling.  
The idea that DA is rewarding is partially informed by studies which demonstrate 
that animals will lever-press to stimulate DA neurons in the ventral tegmental 
area (VTA) or to obtain drugs that impinge on this system.  In the natural setting, 
DA is released during food intake, sex, with unexpected gains such as in 
gambling—all deemed rewarding experiences (Hu, 2016).  In one view, the 
reinforcing power of stimulating DA systems compels an animal to continue to 
seek out rewarding experiences, which, evolutionarily, were aligned with the 
animal’s survival and reproductive success.  Drugs of abuse highjack this 
system—sending it into overdrive by causing enhanced release of and/or 
response to DA.  This DA surge is so rewarding and so motivating that the animal 
(or person) goes to lengths to repeat this experience.  When engaging in 
rewarding behaviors continues despite negative consequences (e.g. financial 
loss, negative health impact, social isolation), this behavior is deemed to be 
‘addiction’ (Konova, Moeller, & Goldstein, 2013; Willuhn, Wanat, Clark, & Phillips, 
2010).  
So, there is a close link between brain areas associated with food intake and 
with other rewarding behaviors and addiction.  Now, as over-eating and obesity 
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have emerged as modern diseases, we can return to studying these circuits in 
their original context.  At the same time, we can use insights from the longer 
history of addiction literature to inform our understanding of how over-eating is 
reinforced and how it may be controlled through behavioral or pharmacological 
interventions in the future. 
As a biological process, addiction is characterized by perturbations in the 
affective and executive control pathways in the brain.  While small amounts of DA 
release in response to food intake is good and leads to consistent and 
appropriate motivation to eat, the large releases caused by high-fat and high-
sugar foods can establish a cycle of craving and dependence similar to that seen 
in addiction.  Over the long-term, the same changes that are seen in the reward 
circuitry under the influence of cocaine and alcohol use can be demonstrated in 
animals and people who have prolonged intake of high-fat and high-sugar foods. 
One area of study in the field of addiction tracks changes in the DA receptors in 
individuals and animals with substance abuse.  In 2001, a prominent study 
conducted by Wang et al. demonstrated that availability of the DA D2-receptor 
(D2R) is decreased in subjects with obesity (Wang et al., 2001), a finding that is 
also seen in subjects with addiction to cocaine (Volkow, Fowler, Wang, & 
Swanson, 2004; Wang, Volkow, Thanos, & Fowler, 2004).  This finding is 
significant because deficiency of these receptors may result in dysfunctional 
responses to rewarding stimuli and promote enhanced drug or food intake.  In 
support of this model, a 2010 study by Johnson and Kenny demonstrated that 
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the compulsive behavior exhibited by their high-fat fed obese rats correlated with 
low D2R expression.  Moreover, viral knockdown of the D2R receptor accelerated 
weight gain and compulsive eating in high-fat fed rats.   
With these studies, we can begin to build a framework for understanding the 
role of DA in promoting food intake.  However, feeding behavior is complex.  The 
decision of how much and when to eat integrates aspects of animal’s motivation, 
body habitus, hormonal state, and perceived value of food.  The role of DA in 
moderating this behavior is similarly complex and so efforts to understand these 
dynamics are helped by narrowing our focus to a one or two DA-responsive brain 
regions.  
 
1.3 Food Intake and the Nucleus Accumbens  
A more basic understanding of how reward system activity patterns govern 
food intake is required to take the next steps in designing both behavioral and 
pharmacological treatments.  Study of the Nucleus Accumbens (NAc) has 
contributed to our understanding of neural mechanisms underlying motivation to 
seek out and consume high calorie food.  The NAc lies within the ventral striatum, 
or limbic division, of the basal ganglia, and its critical functions include 
processing information about rewarding stimuli and directing behavior to 
maximize attainment of reward (Humphries & Prescott, 2010; Wickens, Budd, 
Hyland, & Arbuthnott, 2007).  The role of the NAc in food reward and food intake 
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has been the subject of much study (Kelley, 2004).  The NAc is involved in 
promoting consumption of palatable (rewarding) foods, which, includes those that 
are calorically dense—high in fat and/or sugar.  Much of this work was 
established by Ann Kelley, who demonstrated the importance of NAc projections 
to the lateral hypothalamus (LH, known as a “feeding center”) in reinforcement of 
food intake (Maldonado-Irizarry, Swanson, & Kelley, 1995; Stratford & Kelley, 
1999).   
As noted above, DA is a key neurotransmitter that is released in the NAc in 
response to rewarding stimuli, including food (Bassareo & Di Chiara, 1999; 
Hajnal & Norgren, 2005).  Enhanced DA release in the striatum has been 
implicated in disorders of pathological food intake such as binge eating disorder 
(Avena et al., 2008; Wang et al., 2011), a disorder defined by rapid consumption 
of large amounts of food and loss of control over eating (DSM V).  
Previous studies have demonstrated that inhibition of NAc neurons promotes 
food intake (Stratford, Swanson, & Kelley, 1998). For example, generalized 
inhibition of NAc activity with GABA agonists such as muscimol and baclofen 
causes animals to increase food intake dramatically (Stratford & Kelley, 1997).  
Conversely, electrical stimulation of neurons within NAc inhibits food intake 
(Halpern et al., 2013; Krause, German, Taha, & Fields, 2010).  Evidence 
suggests that these general effects are mediated by a subset of striatal neurons 
(Taha & Fields, 2005, 2006).  It has also been demonstrated that striatal neurons 
exhibit one of two stereotyped responses to food intake (Krause et al., 2010).  
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The majority of recorded neurons, Type 1 neurons (~60%), are inactivated prior 
to initiation of sucrose consumption.  These neurons inactivate approximately 2 
seconds before initiation of licking behavior.  A second population of neurons, 
labeled Type 2 (~30%), respond to the hedonic value of food and increase firing 
rates in response to higher concentrations of sucrose, as compared to low 
sucrose concentrations or water.    
 Presence of inhibited Type 1 neurons is also observed after infusion of the 
pro-feeding peptide, NPY. When injected into the ventral striatum, NPY 
preferentially increases consumption of fat and sugar-containing foods over 
regular chow (Pandit, la Fleur, & Adan, 2013).  In previous work in our lab, I 
conducted recordings of NAc neurons after NPY infusion which demonstrate 
general inhibition (Fig 1) (van den Heuvel et al., 2015), consistent with the model 
of reduced firing. 
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This effect is largely the result of significant suppression in the firing of a subset 
of recorded neurons (~68%), a similar proportion seen in studies of Type 1 
neurons.   There is a gap in knowledge, however, linking the activity of specified 
subsets of dopamine-responsive neurons (expressing D1 and D2 receptors) in 
Fig	  1.	  Neuropeptide	  Y	  (NPY)	  in	  the	  nucleus	  accumbens	  decreases	  neuronal	  activity	  
in	  vivo.	  (A)	  Location	  of	  electrodes	  (black	  spots)	  and	  cannulae	  (filled	  black	  circles)	  
projected	  on	  a	  mouse	  brain	  atlas	  section.	  (B)	  Interspike	  interval	  (ISI)	  histograms	  and	  
waveforms	  from	  a	  single	  unit	  in	  artificial	  cerebrospinal	  fluid	  (aCSF)	  infusion	  sessions	  
(left)	  and	  the	  same	  neuron	  in	  NPY	  infusion	  sessions	  (right).	  (C,	  D)	  Average	  neuronal	  
activity	  for	  NPY	  sessions	  and	  aCSF.	  Gray	  box	  represents	  time	  of	  infusion.	  NPY	  
significantly	  reduces	  firing	  rate	  from	  15	  minutes	  to	  40	  minutes.	  np	  ,	  .05.	  Norm.,	  
normalized.	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the NAc to observed activity patterns during feeding behaviors.  To date, it has 
been difficult, if not impossible, to conduct recordings of specific neuronal sub-
populations (i.e. D1R and D2R –containing medium spiny neurons) in deep brain 
areas such as the ventral striatum.  In 2014, a scientific breakthrough, called fiber 
photometry, made such investigations feasible.  Here, we employ this novel 
method of population neural recording to assess activity patterns of D1R, D2R 
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2 Statement of Purpose 
Previous studies of the role of the NAc in directing feeding behavior have 
demonstrated two main findings: first, inhibition of the NAc is sufficient to initiate 
feeding, and second, a smaller subset of NAc neurons encode the reward value 
of what is ingested.  These functional classes of neurons have been termed Type 
1 (inhibitory) and Type 2 (excitatory) respectively (Taha & Fields, 2005).  
Because the medium spiny neurons (MSNs) of the NAc send GABAergic 
projections to various brain regions including the lateral hypothalamus (LH, 
feeding center) and the ventral tegmental area (VTA, reward center), it has been 
hypothesized that inhibition of these neurons results in release of inhibitory input 
on downstream feeding and reward-seeking circuits (Stratford & Kelley, 1999).   
Anatomical mapping of NAc projections to LH and VTA has demonstrated that 
these primarily consist of D1R+ MSNs.  And activation of this circuit interrupts 
food intake behavior (Krause et al., 2010; O'Connor et al., 2015).  Taken together, 
data suggest that D1R MSNs are those inhibited during food intake (Type 1).  
However, a second body of literature would suggest that D1R MSNs are also 
reward responsive (Calipari et al., 2016).  
Fiber photometry recordings of D1R MSNs during various feeding behaviors 
can help resolve this discrepancy. Based on projection patterns and previous 
manipulations of D1Rs, we hypothesize that D1Rs will exhibit Type 1 inhibition to 
promote food intake.  It also possible, however, that a separate population of 
D1Rs are capable of exhibiting Type II excitation in response to palatable food.  
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We will also explore the activity patterns of D2R MSNs and VTA neurons in food 
intake as we begin to build a more complete understanding of reward system 
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3 Methods 
3.1 Fiber Photometry  
Fiber photometry is a powerful new technique for evaluating neuronal firing in 
vivo by using GCaMP expression in select neurons, and simultaneous excitation 
and monitoring of fluorescent light emission via a fiber optic cable (Gunaydin et 
al., 2014).  Intracellular Ca++ sensors are commonly used to detect action 
potentials and assess neuronal activity.  The GCaMP family of Ca++ sensors 
emit fluorescence when intracellular Ca++ is high (Akerboom et al., 2012; 
Bootman, Rietdorf, Collins, Walker, & Sanderson, 2013; Dreosti, Odermatt, 
Dorostkar, & Lagnado, 2009).  The intensity of this fluorescence scales linearly 
with number of action potentials (Y. Chen, Lin, Kuo, & Knight, 2015).  Historically, 
GCaMP has been used to capture spiking activity of small sets of superficial 
neurons that can be assessed visually.  Fiber photometry uses a femtowatt 
photodetector to capture fluorescence from relatively large populations of cells 
expressing a Ca++ sensor in deep brain structures. This population fluorescence 
is collected through an optical fiber that delivers excitation light to the labeled 
tissue and simultaneously relays emitted fluorescence to a photo-detector (Cui et 
al., 2014; Cui et al., 2013; Gunaydin et al., 2014).  
The goal of fiber photometry is to conduct recordings of native activity of a 
highly specified set of neurons.  Because GCaMP can be delivered to the brain 
area of interest using a viral vector, the population of cells recorded can be 
limited to an area that is approximately 500μm2.  Further neuronal specificity can 
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be achieved using Cre-driver lines to drive expression of the Cre-recombinase 
enzyme in selected cell-types (i.e. D1-cre and D2-cre animals in the present 
study).  GCaMP virus that is “floxed” is only active in the presence of Cre-
recombinase.  We have developed an independent setup for these recordings in 
our lab (pictured below), and have successfully recorded activity in D1R and D2R 
medium spiny neurons in the NAc during instrumental behavior.  For fiber 
photometry, we use 490nm LED excitation light (Thorlabs) that is passed through 
a series of collimators and cleanup filters and finally into a patch cord (Doric). A 
Cre-dependent GCaMP6s is delivered surgically into the NAc or VTA.  A 400 µm 
optical cannula is then implanted targeting the region of interest (NAc, VTA cell 
bodies, or terminals).  For the behavior, a patch cord is connected to an 
indwelling optical cannula and the mice are allowed to move freely.  LED 
stimulation is controlled through a computer program that modulates a sinusoidal 
531Hz signal through an LED driver that can accommodate up to 4 separate 
channels.  A second, control signal, 405 nm LED is modulated simultaneously at 
211Hz and delivered through the same patch cord and into the optical cannula.  
This 405 nm signal does not excite GCaMP and so, serves as a control for 
changes in auto-fluorescence and background noise in the data.   
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The fluorescence data is then collected along with timestamps for animal activity, 
nose pokes, and magazine entries. A strong advantage of this technique lies in 
the ability to evaluate real-time changes in neuronal firing rates in awake, freely 
moving mice.  
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3.2 Animal Surgeries and behavioral training 
Animals: Twenty-seven D1 and D2-dopamine receptor Cre-recombinase male 
and female mice (Drd1a-cre+ and Drd2a-cre+  strain EY262, Gensat, backcrossed 
at least 10 generations to a C57Bl/6 background) weighing 20–30 g were used 
for these studies.  All animals were group-housed until surgical cannula 
implantation when individuals were single-housed. Animals were on a 12 h 
light/dark cycle and provided standard chow and water ad libitum except during 
behavioral training described below, and all animal procedures were performed in 
accordance with the protocol approved by the Institutional Animal Care and Use 
Committee (IACUC). 
 
Behavioral Training:  Sucrose Licking Behavioral boxes (MedAssociates) have 
been set up to accommodate free access to a sipper. To encourage licking, 
animals are water deprived overnight before the first day of training.  Animals are 
then given free access to a 5% or 10% sucrose solution.  After training day 1 
animals are not food or water restricted.  Individual licks on the sipper are 
recorded. For fiber photometry recordings, licks register in real time together with 
fluorescence.  Pellet Eating  Behavioral boxes (MedAssociates) have two 
nosepokes on either side of a pellet receptacle.  Animals were chow restricted to 
maintain 85-90% of bodyweight.  Before the first day of training, animals are 
exposed to purified pellets in their home cages.  During sessions, a nosepoke in 
the correct port results in delivery of a pellet after a 3 second delay while 
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nosepokes in the incorrect port elicits no action.  There is no limit to the number 
of pellets that may be earned.  These sessions are videotaped for later 
behavioral coding.  Videos are analyzed to determine latency between pellet drop 
and magazine entry, pellet retrieval time, and trial errors that include ignored 
pellet or dropped pellet.   
 
Surgical procedure: Animals were anesthetized with an induction dose of 
ketamine (100 mg/kg) and xylazine (10 mg/kg) and maintained with supplemental 
doses of ketamine (30 mg/kg) every 45-60 minutes. The skull was leveled 
between bregma and lambda landmarks, and a single craniotomy was performed 
over the ventral striatum or ventral tegmental area.  First, 0.5 μl of the floxed 
GcAMP6s virus was injected at AP: +1.4, ML: ±0.7, DV: -4.5 (relative to bregma) 
to target D1R and D2R NAc neurons. VTA dopamine neurons were targeted for 
injection at AP: -3.5, ML ±0.35, DV -4.8.  Next, a 400 μm fiberoptic cannula 
(Doric) was placed in the same craniotomy. Cannulas were affixed to the skull 
with dental cement and a screw placed over the parietal bone.  After surgery, all 
animals are single-housed to prevent cage-mates from damaging each other’s 
cannulas.   
 
Fiber photometry recordings: After approximately 2-3 weeks of recovery to 
ensure optimal viral expression and neuronal signal, animals were recorded 
during either the sucrose licking or operant pellet task.  Plugging and unplugging 
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from the fiber optic patch cord was performed under isoflurane anesthesia to 
minimize stress on the animals.  
 
Viral Vectors:  AAV-Ef1a-DIO-GcAMP6s virus for Fiber Photometry was 
purchased from UPenn vector core.  
 
Author’s Contribution: All methods, surgeries and procedures described above 
(including assembly of FP rig) and statistical analyses that follow were conducted 
solely by this author.   
 
 
3.3 Statistical methods and analysis 
The primary goal of fiber photometry analysis is to make sense of a complex 
signal.  This is achieved experimentally by using modulation frequencies that 
maximize signal to noise ratio, and mathematically by careful demodulation of the 
experimental signal such that fluorescence changes are recovered in full.  
 
Modulation of Excitation signals  
The purpose of signal modulation is 2-fold 
1. Modulation allows recovery of a signal that is specific to the excitation light 
and that excludes other sources of fluorescence or noise. 
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2. Modulation allows the researcher to pick a frequency for the excitation 
signal that is away from significant sources of noise that may obscure true 
signal and thereby increases SNR  (Fig 2). 
 
  
In our set-up, modulation is achieved through the TDT RPvdsX software that 
sends out a sine wave of specified frequency and amplitude to the LED driver to 
drive both the excitation light (531Hz) and the background (control) light (211Hz).  
Modulation parameters are chosen such that sources of noise (e.g. electrical 
noise (60Hz), and fluorescent lights (120Hz)) and their harmonics are avoided.  
The excitation and background modulation frequencies should also be chosen to 
minimize harmonics between the two. 
 
Demodulation of excitation signals 
A signal that is modulated to a low-noise frequency can theoretically be 
recovered simply by applying a narrow filter to the raw (observed) signal of 
Fig	  2.	  Choosing	  modulation	  
frequencies.	  	  Example	  noise	  band	  
1/f	  	  demonstrates	  decreasing	  
amplitude	  of	  noise	  envelope	  as	  
frequency	  gets	  larger.	  	  Two	  
example	  signals	  1	  and	  2	  have	  the	  
same	  amplitude	  but	  are	  differently	  
obscured	  by	  noise.	  Signal	  1	  S:N	  ≅	  
3/1;	  Signal	  2	  S:N	  ≅	  6.5/1	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detected fluorescence that removes all frequencies that are not at the modulated 
frequency (plus some small bandwidth).  However, it is “challenging to design 
very narrow, (high Q) band-pass filters with discrete components.  If the 
specifications call for an extremely narrow filter, it may even be impossible.” 
(Orozco, 2014)(Fig. 3). 
 
 
Demodulation allows for recovery of signal using a simple low-pass filter by 
moving signal of interest to DC frequency (0Hz). (Fig 4) 
Fig.	  3.	  Fourier	  transform	  of	  observed	  raw	  signal	  demonstrates	  a	  peak	  at	  the	  
chosen	  modulation	  frequency.	  	  Even	  though	  signal	  to	  noise	  ration	  is	  
acceptable,	  there	  are	  significant	  sources	  of	  noise	  at	  frequencies	  close	  to	  the	  
modulation	  frequency.	  	  	  It	  would	  be	  challenging	  to	  design	  a	  bandpass	  filter	  to	  
recover	  only	  this	  frequency	  and	  exclude	  nearby	  noise.	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To recover the full excitation signal accurately, a reference signal is mixed with 
the measured signal to demodulate.  Reference signal is mixed both in-phase 
and out-of-phase and then these components are added in quadrature to recover 
Fig	  4.	  A	  pure	  reference	  signal	  is	  mixed	  (multiplied)	  with	  the	  observed	  raw	  signal.	  	  
Fourier	  transform	  of	  the	  raw	  signal	  demonstrates	  a	  peak	  at	  the	  experimental	  modulation	  
frequency	  of	  interest	  (thick	  band,	  1kHz)	  but	  also	  demonstrates	  	  large	  amplitude	  noise	  at	  
50Hz,	  1.5kHz	  and	  2.5kHz.	  	  Mixing	  a	  pure	  1kHz	  reference	  signal	  creates	  double	  peaks	  at	  
each	  observed	  frequency	  that	  are	  equal	  to	  the	  reference	  frequency	  +/-­‐	  each	  observed	  
frequency.	  	  As	  a	  result,	  our	  experimental	  signal	  moves	  to	  zero	  and	  all	  other	  sources	  of	  
noise	  move	  away	  from	  zero.	  	  This	  makes	  recovery	  of	  the	  experimental	  signal	  easy	  
through	  a	  simple	  low-­‐pass	  filter.	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any loss of signal that occurs from phase shifts between reference signal and 
modulated (experimental) signals (Fig. 5) 
 
 
So, for demodulation, we apply the following equation to mix a reference signal 
with our observed raw signal (Eq. 1). 
Asin(2πfmt) x B(sin(2πfmt) = ½ AB - ½ ABcos(2π2fmt) 
Where A = experimental signal, B = reference signal, fm = frequency of 
modulation.  Then, to account for phase shifts, 
Expsig x Refsin(sig) = I 
Expsig x Refcos(sig) = Q 
Expsig = √I2 + Q2 
Fig	  5.	  	  Mixing	  with	  a	  reference	  signal	  and	  adding	  in	  quadrature.	  To	  account	  for	  shift	  
in	  phase	  between	  reference	  and	  recovered	  signal	  (which	  will	  commonly	  happen	  if	  there	  
are	  any	  filters	  in	  the	  input	  pathway,	  for	  example).	  	  Reference	  is	  mixed	  both	  in-­‐phase	  and	  
out-­‐of-­‐phase	  to	  give	  full	  amplitude	  of	  experimental	  signal.	  	  This	  is	  called,	  adding	  in	  
quadrature	  I.Q.	  and	  comes	  from	  the	  Pythagorean	  theorem.	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This process is repeated using the same raw observed signal referenced against 
the modulation frequency of the background (control) signal to recover 
background fluorescence during experimental trials.   
Finally, a low-pass filter is applied ~ 15Hz during live collection and later 
further filtered at 2Hz during post-processing to recover both GCaMP-related and 
background fluorescence signals. 
 
Normalizing Fluorescence signal  
dF/F can be calculated in a number of ways, and consensus still has not evolved 
in the literature.  For the following experiments, we use the recovered 490 nm 
(excitation) signal relative to some baseline local to an individual trial or across 
whole experimental session (depending upon how much bleaching occurs) 
490nm signal/baseline 
dF/F can be calculated by referencing the normalized 490 nm signal against the 
normalized 405 nm (background) signal that is used in this set-up. 
490nm signal/405nm signal 
To account for bleaching, the 405nm signal can be fitted to a linear least-squares 
regression line so dF/F becomes: 
dF/F = (490 signal – fitted 405 signal)/fitted 405 signal 
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4 Results 
My first aim was to establish the fiber photometry technique and confirm that 
it works.  To do this, D2-Cre animals expressing Cre recombinase in VTA-TH 
neurons (that release dopamine, Fig. 6B) were infused with virus to express 
GCaMP6s and fitted with a fiber-optic cannula.  VTA-TH neurons are 
dopaminergic and release DA in the NAc in response to palatable food intake.  
Recordings of DA-neuron activity during sucrose licking demonstrate large 
increases in firing in response to 10% sucrose ingestion (Fig. 6C-D, n = 11, 
average normalized fluorescence (aFn) peak =1.7 at lick onset).   These 
increases in firing were concentrated at the beginning of lick bouts and were 
somewhat attenuated over time (Fig. 6E,G aFnstart = 1.015 ± 1.0280e-4 in first four 
lick bouts compared to the last four aFnend = 1.007 ± 0.7449e-5, p<0.0001 by one-
way ANOVA).  To test sensitivity of fiber photometry to changes in population 
activity further, animals were injected with a low-dose D2-agonist, quinpirole 
(0.001mg/kg administered i.p.).  Because the D2R is Gi-coupled, firing of VTA-DA 
neurons is attenuated in the beginning of the trial.  As quinpirole wears off, VTA 
firing strengthens, in contrast to attenuation seen during earlier sucrose trials (Fig. 
6F,G aFnveh = 1.007 ± 0.7449e-5 in last four lick bouts compared to aFnquin = 
1.026 ± 1.8842e-4, p<0.0001 by one-way ANOVA).   
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Fig.	  6	  Activity	  of	  VTA	  dopamine	  neurons	  during	  sucrose	  licking.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(A)	  Representative	  image	  of	  fiber	  photometry	  set	  up,	  with	  animal	  tethered	  during	  recording	  
session.	  (B)	  VTA	  neurons	  expressing	  TH	  (marker	  of	  dopamine	  synthesis)	  also	  express	  D2	  
receptor	  as	  indicated	  by	  the	  presence	  of	  Cre	  recombinase	  in	  these	  cells	  (D2-­‐cre	  animal,	  95%	  
TH+	  neurons	  express	  Cre,	  100%	  of	  Cre+	  neurons	  are	  also	  TH+).	  (C)	  Example	  raw	  
fluorescence	  trace	  (in	  blue)	  during	  15	  minutes	  of	  licking	  (gray	  bars	  indicate	  individual	  licks).	  
(D)	  	  Mean	  and	  s.e.m	  of	  normalized	  signal	  for	  VTA	  animals	  during	  sucrose	  licking	  
demonstrates	  sharp	  increase	  in	  activity	  after	  first	  lick	  (dashed	  line)	  of	  analyzed	  lick	  bouts	  (n	  
=	  12	  animals,	  229	  bouts).	  (E,	  F)	  Example	  1	  hour	  licking	  sessions	  for	  the	  same	  VTA	  animal	  
after	  i.p.	  injection	  with	  saline	  (E)	  and	  quinpirole	  (F).	  Top	  panel:	  Individual	  licks	  were	  binned	  
into	  clustered	  bouts	  (defined	  by	  at	  least	  5	  consecutive	  licks	  occurred	  within	  1	  sec)	  and	  then	  
arranged	  by	  bouts	  separated	  by	  10	  seconds	  to	  provide	  a	  clean	  baseline	  for	  analysis	  of	  
fluorescent	  signal	  (n=9	  and	  10	  bouts	  for	  veh	  and	  quinpirole	  examples,	  respectively).	  	  Bottom	  
panel:	  heatmap	  of	  normalized	  signal	  intensity	  aligned	  to	  lick	  bouts	  such	  that	  each	  line	  
corresponds	  to	  one	  lick	  bout.	  (G)	  Mean	  and	  s.e.m	  of	  normalized	  signal	  for	  the	  first	  four	  lick	  
bouts	  vs	  last	  four	  lick	  bouts	  of	  each	  session	  demonstrates	  significant	  attenuation	  of	  signal	  
under	  normal	  conditions	  is	  reversed	  when	  D2-­‐agonist	  quinpirole	  is	  onboard	  (p<0.0001,	  one-­‐
way	  ANOVA).	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Having established reliable recordings under various conditions, we next 
examined activity of D1R and D2R NAc MSNs during sucrose licking.  As 
expected, D1R and D2R neurons demonstrate opposite activity patterns during 
sucrose licking.  D1R neurons shut down immediately prior to lick onset (Fig. 7 
B,D prelick ΔFnD1 = 0.005 ± 0.00015 compared to postlick ΔFnD1 = -0.0338 ± 
0.00036, two-tailed t-test, p<0.0001).  As hypothesized, this pattern of activity is 
consistent with the Type 1 pattern previously described in NAc neurons (Krause 
et al., 2010; Taha & Fields, 2005).  In contrast, D2Rs demonstrate a strong 
increase in signal at lick onset (Fig. 7C,E peak FnD2 = 1.0632 ± 0.0011). This 
pattern of activity is consistent with the Type 2 excitatory pattern of activity.  
 




Fig.	  7	  Differential	  activity	  of	  D1R	  and	  D2R	  neuron	  activity	  during	  sucrose	  licking.	  	  
(A)	  Representative	  image	  of	  cannula	  placement	  and	  GCaMP6s	  viral	  expression	  in	  the	  
NAc.	  (B,C)	  	  Example	  1	  hour	  licking	  session	  for	  a	  D1(B)	  and	  D2(C)	  animal.	  Top	  panel:	  
Individual	  licks	  were	  binned	  into	  clustered	  bouts	  (defined	  by	  at	  least	  5	  consecutive	  licks	  
occurred	  within	  1	  sec)	  and	  then	  arranged	  by	  bouts	  separated	  by	  10	  seconds	  to	  provide	  a	  
clean	  baseline	  for	  analysis	  of	  fluorescent	  signal	  (n=17	  and	  14	  bouts	  for	  D1	  and	  D2	  
examples,	  respectively).	  	  Bottom	  panel:	  heatmap	  of	  normalized	  signal	  intensity	  aligned	  
to	  lick	  bouts	  such	  that	  each	  line	  corresponds	  to	  one	  lick	  bout.	  (D,E)	  	  Mean	  and	  s.e.m	  of	  
normalized	  signal	  for	  example	  sessions	  depicted	  in	  B	  and	  C.	  	  (F)	  Mean	  and	  s.e.m	  of	  
normalized	  signal	  for	  all	  D1	  and	  D2	  animals	  first	  day	  of	  sucrose	  licking	  (For	  D1,	  n	  =	  4	  
animals,	  66	  bouts.	  	  For	  D2,	  n=2	  animals,	  32	  bouts.	  	  p<0.0001,	  two-­‐tailed	  t-­‐test).	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Studying sucrose licking allows us to relate FP data to electrophysiological 
studies of Type 1 or Type 2 neurons, however this single behavior overlaps 
several aspects of feeding (e.g. approach, decision, initiation, intake, reward, and 
cessation).  To understand better the roles of D1R and D2R neurons in these 
distinct aspects of feeding behavior, we trained animals on an operant feeding 
task in which they nose-poked for pellets.  This task allows us to separate the 
decision and action initiation phases of intake from reward receipt for more in-
depth analysis.  
Analysis of poke and reward-phase fluorescence on last day of training, when 
animals had adequately learned the task (Fig. 8B,C) demonstrates that D1R and 
D2R neurons continue to have opposite patterns of activity at action-initiation 
during the poke phase of each trial (Fig. 8D). However, when reward-phase 
fluorescence is considered separately, both D1R and D2R neurons have 
increases in activity associated with food intake (Fig. 8E).  
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Fig.	  8	  Differential	  activity	  of	  D1R	  and	  D2R	  neuron	  activity	  during	  operant	  pellet	  
eating	  task.	  	  (A)	  Schematic	  of	  operant	  pellet	  task.	  	  Nosepoke	  in	  the	  correct	  port	  results	  
in	  delivery	  of	  purified	  sweet	  pellet	  3	  seconds	  later.	  	  (B)	  	  Learning	  curves	  for	  both	  D1	  
(n=6)	  and	  D2-­‐cre	  (n=5)	  strains.	  	  In	  first	  2	  days	  of	  training,	  animals	  poke	  equally	  in	  the	  
active	  and	  inactive	  noseports.	  	  By	  Day	  3,	  however	  animals	  have	  learned	  which	  port	  is	  the	  
active	  (correct	  )	  one	  and	  pokes	  in	  the	  incorrect	  port	  decline	  significantly	  (mean+s.e.m	  
Day	  1	  compared	  to	  Day3,	  p<0.008,	  by	  one-­‐way	  ANOVA).	  Individual	  animal	  data	  points	  
plotted	  along	  with	  mean	  and	  s.e.m.	  	  	  (C)	  Over	  4	  days	  of	  training,	  food	  restricted	  animals	  
earn	  more	  pellets	  as	  they	  learn	  that	  correct	  nosepokes	  result	  in	  pellet	  delivery.	  	  There	  is	  
no	  limit	  on	  number	  of	  pellets	  earned.	  	  On	  average,	  animals	  of	  both	  strains	  earn	  and	  eat	  
45	  pellets	  per	  1	  hour	  session.	  	  (D)	  Analysis	  of	  the	  nosepoke	  phase	  of	  repeated	  trials	  on	  
day	  4	  of	  training	  demonstrates	  significant	  difference	  in	  activity	  pattern	  of	  D1R	  and	  D2R	  
neuron	  populations.	  (For	  D1,	  n	  =	  6	  animals,	  290	  trials.	  	  For	  D2,	  n=5	  animals,	  203	  trials.	  	  
p=	  0.0072,	  two-­‐tailed	  t-­‐test.).	  (E)	  Analysis	  of	  the	  reward	  phase	  of	  repeated	  trials	  on	  day	  4	  
of	  training	  demonstrates	  significant	  difference	  in	  activity	  pattern	  of	  D1R	  and	  D2R	  neuron	  
populations.	  (For	  D1,	  n	  =	  6	  animals,	  290	  trials.	  	  For	  D2,	  n=5	  animals,	  203	  trials.	  	  
p<0.0001,	  two-­‐tailed	  t-­‐test).	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5 Discussion 
The present study accomplishes two aims.  First, we have validated a new 
technique, fiber photometry, to conduct cell-type-specific recordings of neuronal 
activity of medium spiny neurons in the nucleus accumbens.  Second, we build 
on literature assessing the roles of NAc D1R and D2R neurons in food intake.  
Earlier studies have suggested differential roles of D1R and D2R neurons based 
on anatomical tracing, pharmacological and optogenetic manipulation of these 
cells. However this is the first direct observation of these populations during food 
intake.   
Our D1R results are consistent with earlier hypotheses that these neurons 
gate intake behaviors (O'Connor et al., 2015).  In both the licking and nosepoke 
paradigms, D1R activity is rapidly and significantly attenuated at the start of each 
trial.  During sucrose licking, D1R suppression is reliably sustained throughout 
the lick bout and signal rebounds after the final lick of each bout. These findings 
are consistent with the patterns of activity previously described in 
electrophysiological recordings of NAc gating neurons originally described by in 
2005 (Taha & Fields, 2005).  This suggests that the previously characterized 
neurons might be D1R expressing cells. 
There is a slight discrepancy, however, between our fiber photometry 
recordings and electrophysiological recordings of Type 1 neurons in that Type 1 
neurons classically become inhibited approximately one second before licking 
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onset.  While this pattern held in some examples (Fig. 7D), on average, we found 
that, decreases in activity occurred right on the first lick (Fig. 7F).  This 
discrepancy is likely due to a difference in technique.  Electrophysiological 
recordings have a time resolution of 1-2 ms and so changes in neuronal activity 
are accessed immediately.  We used GCaMP6s (“6” indicates this is the sixth 
generation of GCaMP molecules, “s” stands for slow) for our fiber photometry 
recordings.  Although there are faster versions of the GCaMP6 molecule, we 
opted for 6s because it allows it has the best signal to noise ratio, and largest 
change in fluorescence per action potential.  However, GCaMP6s also has a 
longer rise time (approx. 500 ms) and decay time (T1/2 = 3 s for 100 action 
potentials) than other GCaMP6 molecules (T. W. Chen et al., 2013).  So, while 
we have maximized our signal using this construct, there is a potential delay 
between changes in signal and real-time behavior of up to 500ms at onset and 1-
2 seconds at offset.  Because we do not know what the exact correction would be 
in each animal (it may vary with size of infection and number of neurons 
captured) we have not attempted to compensate for these small time-shifts in 
fluorescence data relative to behavioral data.   
In contrast to licking behavior, the operant pellet task allowed us to assess 
action initiation and reward retrieval as discrete timepoints.  This paradigm also 
keeps the size of reward constant (1 pellet), whereas in free licking the animal is 
in control of lick bout size and spacing between bouts.  With this task, inhibition of 
D1Rs did anticipate action initiation by 1-2 seconds (Fig. 8D).  Reasons for this 
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difference are not clear.  It could be that more motor coordination and planning is 
required to accomplish a nosepoke than a lick and so pre-poke inhibition begins 
earlier.  In order to reduce the number of accidental nosepokes when the animal 
is exploring the noseport, our nosepoke sensor is recessed such that a deep, 
somewhat sustained (> 300ms) poke is required to earn a pellet.   
The operant pellet model also differs from sucrose licking by dissociating 
motor action from reward receipt and introduces a delay between to two.  Under 
these conditions, we see D1R signal begin to return to baseline before reward is 
delivered and peaks immediately after the animal retrieves the food pellet (Fig. 
8D,E).  In this case, it is difficult to say whether the D1R signal increase after 
pellet retrieval represents a return to baseline after previous suppression or 
excitation due to reward.  Alternatively, because these are population recordings, 
we may be seeing the activity from two separate sub-populations of D1R neurons.  
One set (the Type 1), undergoes sustained inhibition at the onset of each trial 
while a second set of D1R neurons may increase activity in anticipation of reward 
and peak after reward receipt –a pattern more similar to Type 2 neurons.  In this 
case, these neurons should be sensitive to timing of reward delivery as well as 
value of reward delivered.  Further studies are necessary to resolve this question, 
however, here we have established an appropriate paradigm for testing reward 
sensitivity independent of action initiation.   
Our hypotheses about activity patterns of D2R MSNs during intake were less 
clear, due to lack of consensus in the literature about the role these neurons.  
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The D2 receptor is Gi-coupled and so, classically, when dopamine is high (as it is 
in response to food intake) these neurons are thought to be inhibited. Recent 
data challenge the classical understanding of the roles of D2 in reward and 
motivation.  In 2010 Cui et al. demonstrated that in the dorsal striatum, some D2s 
are activated with action initiation (Cui et al., 2013).  As mentioned previously, 
studies of D2 receptor availability suggest that obesity is associated with a 
decrease in the number of D2 receptors in the striatum (Johnson & Kenny, 2010; 
Wang et al., 2001).  Loss of the inhibitory D2 receptor should lead to greater 
neuronal excitability and thus, according to these data, increased feeding would 
be associated with increased D2R neuron activity.   
Our investigation of D2R MSNs suggests that these neurons correspond to 
Type 2 (excitatory) neurons found by Taha and Fields.  These neurons are 
reward responsive and peak approximately one second after the start of sucrose 
consumption (Fig. 7E,F).  Similarly, during the pellet task, D2R neurons peak 
after pellet delivery (Fig. 8E).  Of note, video analysis of pellet task sessions 
demonstrates that well trained animals retrieve the food pellet almost 
immediately and so the peak seen after pellet delivery is associated with 
ingestion, not just reward receipt.  Our analysis also demonstrates a peak in D2R 
neuron activity after nosepoke (Fig. 8D).  The NAc is an important center for 
reward-associated learning and several studies have demonstrated that neurons 
in this structure respond to reward-predictive cues.  Thus far, it is unclear 
whether the D1R or D2R population of neurons is more responsive to predictive 
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cues.  In 2016, Soares-Cunha et al. demonstrated that activation of D2 neurons 
during reward-predictive cue enhanced lever pressing (Soares-Cunha et al., 
2016).  The present study provides further evidence that activation of D2R 
neurons encodes information about motivation and reward.   
In sum, observing the activity of D1R and D2R neurons of the NAc fills gaps 
in our knowledge of normal regulation of these sets of neurons during appetitive 
and consummatory behavior.  This is critical for developing a more accurate 














	   42	  
6 References 
Akerboom,	  J.,	  Chen,	  T.	  W.,	  Wardill,	  T.	  J.,	  Tian,	  L.,	  Marvin,	  J.	  S.,	  Mutlu,	  S.,	  .	  .	  .	  Looger,	  L.	  L.	  
(2012).	  Optimization	  of	  a	  GCaMP	  calcium	  indicator	  for	  neural	  activity	  
imaging.	  J	  Neurosci,	  32(40),	  13819-­‐13840.	  doi:10.1523/JNEUROSCI.2601-­‐
12.2012	  
Appel,	  L.	  J.,	  Clark,	  J.	  M.,	  Yeh,	  H.	  C.,	  Wang,	  N.	  Y.,	  Coughlin,	  J.	  W.,	  Daumit,	  G.,	  .	  .	  .	  Brancati,	  
F.	  L.	  (2011).	  Comparative	  effectiveness	  of	  weight-­‐loss	  interventions	  in	  
clinical	  practice.	  N	  Engl	  J	  Med,	  365(21),	  1959-­‐1968.	  
doi:10.1056/NEJMoa1108660	  
Avena,	  N.	  M.,	  Rada,	  P.,	  &	  Hoebel,	  B.	  G.	  (2008).	  Evidence	  for	  sugar	  addiction:	  
behavioral	  and	  neurochemical	  effects	  of	  intermittent,	  excessive	  sugar	  intake.	  
Neurosci	  Biobehav	  Rev,	  32(1),	  20-­‐39.	  doi:10.1016/j.neubiorev.2007.04.019	  
Bassareo,	  V.,	  &	  Di	  Chiara,	  G.	  (1999).	  Differential	  responsiveness	  of	  dopamine	  
transmission	  to	  food-­‐stimuli	  in	  nucleus	  accumbens	  shell/core	  compartments.	  
Neuroscience,	  89(3),	  637-­‐641.	  	  
Berkel,	  L.	  A.,	  Poston,	  W.	  S.,	  Reeves,	  R.	  S.,	  &	  Foreyt,	  J.	  P.	  (2005).	  Behavioral	  
interventions	  for	  obesity.	  J	  Am	  Diet	  Assoc,	  105(5	  Suppl	  1),	  S35-­‐43.	  
doi:10.1016/j.jada.2005.02.031	  
Bootman,	  M.	  D.,	  Rietdorf,	  K.,	  Collins,	  T.,	  Walker,	  S.,	  &	  Sanderson,	  M.	  (2013).	  Ca2+-­‐
sensitive	  fluorescent	  dyes	  and	  intracellular	  Ca2+	  imaging.	  Cold	  Spring	  Harb	  
Protoc,	  2013(2),	  83-­‐99.	  doi:10.1101/pdb.top066050	  
Calipari,	  E.	  S.,	  Bagot,	  R.	  C.,	  Purushothaman,	  I.,	  Davidson,	  T.	  J.,	  Yorgason,	  J.	  T.,	  Pena,	  C.	  
J.,	  .	  .	  .	  Nestler,	  E.	  J.	  (2016).	  In	  vivo	  imaging	  identifies	  temporal	  signature	  of	  D1	  
and	  D2	  medium	  spiny	  neurons	  in	  cocaine	  reward.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A,	  
113(10),	  2726-­‐2731.	  doi:10.1073/pnas.1521238113	  
Carvajal,	  R.,	  Wadden,	  T.	  A.,	  Tsai,	  A.	  G.,	  Peck,	  K.,	  &	  Moran,	  C.	  H.	  (2013).	  Managing	  
obesity	  in	  primary	  care	  practice:	  a	  narrative	  review.	  Ann	  N	  Y	  Acad	  Sci,	  1281,	  
191-­‐206.	  doi:10.1111/nyas.12004	  
Chen,	  T.	  W.,	  Wardill,	  T.	  J.,	  Sun,	  Y.,	  Pulver,	  S.	  R.,	  Renninger,	  S.	  L.,	  Baohan,	  A.,	  .	  .	  .	  Kim,	  D.	  
S.	  (2013).	  Ultrasensitive	  fluorescent	  proteins	  for	  imaging	  neuronal	  activity.	  
Nature,	  499(7458),	  295-­‐300.	  doi:10.1038/nature12354	  
Chen,	  Y.,	  Lin,	  Y.	  C.,	  Kuo,	  T.	  W.,	  &	  Knight,	  Z.	  A.	  (2015).	  Sensory	  detection	  of	  food	  
rapidly	  modulates	  arcuate	  feeding	  circuits.	  Cell,	  160(5),	  829-­‐841.	  
doi:10.1016/j.cell.2015.01.033	  
Cooper,	  Z.,	  Doll,	  H.	  A.,	  Hawker,	  D.	  M.,	  Byrne,	  S.,	  Bonner,	  G.,	  Eeley,	  E.,	  .	  .	  .	  Fairburn,	  C.	  G.	  
(2010).	  Testing	  a	  new	  cognitive	  behavioural	  treatment	  for	  obesity:	  A	  
randomized	  controlled	  trial	  with	  three-­‐year	  follow-­‐up.	  Behav	  Res	  Ther,	  48(8),	  
706-­‐713.	  doi:10.1016/j.brat.2010.03.008	  
Cui,	  G.,	  Jun,	  S.	  B.,	  Jin,	  X.,	  Luo,	  G.,	  Pham,	  M.	  D.,	  Lovinger,	  D.	  M.,	  .	  .	  .	  Costa,	  R.	  M.	  (2014).	  
Deep	  brain	  optical	  measurements	  of	  cell	  type-­‐specific	  neural	  activity	  in	  
behaving	  mice.	  Nat	  Protoc,	  9(6),	  1213-­‐1228.	  doi:10.1038/nprot.2014.080	  
Cui,	  G.,	  Jun,	  S.	  B.,	  Jin,	  X.,	  Pham,	  M.	  D.,	  Vogel,	  S.	  S.,	  Lovinger,	  D.	  M.,	  &	  Costa,	  R.	  M.	  (2013).	  
Concurrent	  activation	  of	  striatal	  direct	  and	  indirect	  pathways	  during	  action	  
initiation.	  Nature,	  494(7436),	  238-­‐242.	  doi:10.1038/nature11846	  
	   43	  
Davis,	  C.,	  Curtis,	  C.,	  Levitan,	  R.	  D.,	  Carter,	  J.	  C.,	  Kaplan,	  A.	  S.,	  &	  Kennedy,	  J.	  L.	  (2011).	  
Evidence	  that	  'food	  addiction'	  is	  a	  valid	  phenotype	  of	  obesity.	  Appetite,	  57(3),	  
711-­‐717.	  doi:10.1016/j.appet.2011.08.017	  
Dreosti,	  E.,	  Odermatt,	  B.,	  Dorostkar,	  M.	  M.,	  &	  Lagnado,	  L.	  (2009).	  A	  genetically	  
encoded	  reporter	  of	  synaptic	  activity	  in	  vivo.	  Nat	  Methods,	  6(12),	  883-­‐889.	  
doi:10.1038/nmeth.1399	  
Eichen,	  D.	  M.,	  Lent,	  M.	  R.,	  Goldbacher,	  E.,	  &	  Foster,	  G.	  D.	  (2013).	  Exploration	  of	  "food	  
addiction"	  in	  overweight	  and	  obese	  treatment-­‐seeking	  adults.	  Appetite,	  67,	  
22-­‐24.	  doi:10.1016/j.appet.2013.03.008	  
Ely,	  A.	  C.,	  Banitt,	  A.,	  Befort,	  C.,	  Hou,	  Q.,	  Rhode,	  P.	  C.,	  Grund,	  C.,	  .	  .	  .	  Ellerbeck,	  E.	  (2008).	  
Kansas	  primary	  care	  weighs	  in:	  a	  pilot	  randomized	  trial	  of	  a	  chronic	  care	  
model	  program	  for	  obesity	  in	  3	  rural	  Kansas	  primary	  care	  practices.	  J	  Rural	  
Health,	  24(2),	  125-­‐132.	  doi:10.1111/j.1748-­‐0361.2008.00148.x	  
Fabricatore,	  A.	  N.,	  &	  Wadden,	  T.	  A.	  (2006).	  Obesity.	  Annu	  Rev	  Clin	  Psychol,	  2,	  357-­‐377.	  
doi:10.1146/annurev.clinpsy.2.022305.095249	  
Fabricatore,	  A.	  N.,	  Wadden,	  T.	  A.,	  Ebbeling,	  C.	  B.,	  Thomas,	  J.	  G.,	  Stallings,	  V.	  A.,	  
Schwartz,	  S.,	  &	  Ludwig,	  D.	  S.	  (2011).	  Targeting	  dietary	  fat	  or	  glycemic	  load	  in	  
the	  treatment	  of	  obesity	  and	  type	  2	  diabetes:	  a	  randomized	  controlled	  trial.	  
Diabetes	  Res	  Clin	  Pract,	  92(1),	  37-­‐45.	  doi:10.1016/j.diabres.2010.12.016	  
Finkelstein,	  E.	  A.,	  Trogdon,	  J.	  G.,	  Cohen,	  J.	  W.,	  &	  Dietz,	  W.	  (2009).	  Annual	  medical	  
spending	  attributable	  to	  obesity:	  payer-­‐and	  service-­‐specific	  estimates.	  Health	  
Aff	  (Millwood),	  28(5),	  w822-­‐831.	  doi:10.1377/hlthaff.28.5.w822	  
Force,	  U.	  P.	  S.	  T.	  (2003).	  Screening	  for	  obesity	  in	  adults:	  recommnendations	  and	  
rationale.	  Annals	  of	  Internal	  Medicine(139),	  930-­‐932.	  	  
Gearhardt,	  A.	  N.,	  Corbin,	  W.	  R.,	  &	  Brownell,	  K.	  D.	  (2009).	  Preliminary	  validation	  of	  
the	  Yale	  Food	  Addiction	  Scale.	  Appetite,	  52(2),	  430-­‐436.	  
doi:10.1016/j.appet.2008.12.003	  
Gunaydin,	  L.	  A.,	  Grosenick,	  L.,	  Finkelstein,	  J.	  C.,	  Kauvar,	  I.	  V.,	  Fenno,	  L.	  E.,	  Adhikari,	  
A.,	  .	  .	  .	  Deisseroth,	  K.	  (2014).	  Natural	  neural	  projection	  dynamics	  underlying	  
social	  behavior.	  Cell,	  157(7),	  1535-­‐1551.	  doi:10.1016/j.cell.2014.05.017	  
Hajnal,	  A.,	  &	  Norgren,	  R.	  (2005).	  Taste	  pathways	  that	  mediate	  accumbens	  dopamine	  
release	  by	  sapid	  sucrose.	  Physiol	  Behav,	  84(3),	  363-­‐369.	  
doi:10.1016/j.physbeh.2004.12.014	  
Halpern,	  C.	  H.,	  Tekriwal,	  A.,	  Santollo,	  J.,	  Keating,	  J.	  G.,	  Wolf,	  J.	  A.,	  Daniels,	  D.,	  &	  Bale,	  T.	  
L.	  (2013).	  Amelioration	  of	  binge	  eating	  by	  nucleus	  accumbens	  shell	  deep	  
brain	  stimulation	  in	  mice	  involves	  D2	  receptor	  modulation.	  J	  Neurosci,	  33(17),	  
7122-­‐7129.	  doi:10.1523/JNEUROSCI.3237-­‐12.2013	  
Hu,	  H.	  (2016).	  Reward	  and	  Aversion.	  Annu	  Rev	  Neurosci,	  39,	  297-­‐324.	  
doi:10.1146/annurev-­‐neuro-­‐070815-­‐014106	  
Humphries,	  M.	  D.,	  &	  Prescott,	  T.	  J.	  (2010).	  The	  ventral	  basal	  ganglia,	  a	  selection	  
mechanism	  at	  the	  crossroads	  of	  space,	  strategy,	  and	  reward.	  Prog	  Neurobiol,	  
90(4),	  385-­‐417.	  doi:10.1016/j.pneurobio.2009.11.003	  
Johnson,	  P.	  M.,	  &	  Kenny,	  P.	  J.	  (2010).	  Dopamine	  D2	  receptors	  in	  addiction-­‐like	  
reward	  dysfunction	  and	  compulsive	  eating	  in	  obese	  rats.	  Nat	  Neurosci,	  13(5),	  
635-­‐641.	  doi:10.1038/nn.2519	  
	   44	  
Kelley,	  A.	  E.	  (2004).	  Ventral	  striatal	  control	  of	  appetitive	  motivation:	  role	  in	  
ingestive	  behavior	  and	  reward-­‐related	  learning.	  Neurosci	  Biobehav	  Rev,	  27(8),	  
765-­‐776.	  doi:10.1016/j.neubiorev.2003.11.015	  
Konova,	  A.	  B.,	  Moeller,	  S.	  J.,	  &	  Goldstein,	  R.	  Z.	  (2013).	  Common	  and	  distinct	  neural	  
targets	  of	  treatment:	  changing	  brain	  function	  in	  substance	  addiction.	  
Neurosci	  Biobehav	  Rev,	  37(10	  Pt	  2),	  2806-­‐2817.	  
doi:10.1016/j.neubiorev.2013.10.002	  
Kothari,	  S.	  N.,	  Borgert,	  A.	  J.,	  Kallies,	  K.	  J.,	  Baker,	  M.	  T.,	  &	  Grover,	  B.	  T.	  (2016).	  Long-­‐
term	  (>10-­‐year)	  outcomes	  after	  laparoscopic	  Roux-­‐en-­‐Y	  gastric	  bypass.	  Surg	  
Obes	  Relat	  Dis.	  doi:10.1016/j.soard.2016.12.011	  
Krause,	  M.,	  German,	  P.	  W.,	  Taha,	  S.	  A.,	  &	  Fields,	  H.	  L.	  (2010).	  A	  pause	  in	  nucleus	  
accumbens	  neuron	  firing	  is	  required	  to	  initiate	  and	  maintain	  feeding.	  J	  
Neurosci,	  30(13),	  4746-­‐4756.	  doi:10.1523/JNEUROSCI.0197-­‐10.2010	  
Magro,	  D.	  O.,	  Geloneze,	  B.,	  Delfini,	  R.,	  Pareja,	  B.	  C.,	  Callejas,	  F.,	  &	  Pareja,	  J.	  C.	  (2008).	  
Long-­‐term	  weight	  regain	  after	  gastric	  bypass:	  a	  5-­‐year	  prospective	  study.	  
Obes	  Surg,	  18(6),	  648-­‐651.	  doi:10.1007/s11695-­‐007-­‐9265-­‐1	  
Maldonado-­‐Irizarry,	  C.	  S.,	  Swanson,	  C.	  J.,	  &	  Kelley,	  A.	  E.	  (1995).	  Glutamate	  receptors	  
in	  the	  nucleus	  accumbens	  shell	  control	  feeding	  behavior	  via	  the	  lateral	  
hypothalamus.	  J	  Neurosci,	  15(10),	  6779-­‐6788.	  	  
Maleckas,	  A.,	  Gudaityte,	  R.,	  Petereit,	  R.,	  Venclauskas,	  L.,	  &	  Velickiene,	  D.	  (2016).	  
Weight	  regain	  after	  gastric	  bypass:	  etiology	  and	  treatment	  options.	  Gland	  
Surg,	  5(6),	  617-­‐624.	  doi:10.21037/gs.2016.12.02	  
Meule,	  A.,	  Heckel,	  D.,	  &	  Kubler,	  A.	  (2012).	  Factor	  structure	  and	  item	  analysis	  of	  the	  
Yale	  Food	  Addiction	  Scale	  in	  obese	  candidates	  for	  bariatric	  surgery.	  Eur	  Eat	  
Disord	  Rev,	  20(5),	  419-­‐422.	  doi:10.1002/erv.2189	  
O'Connor,	  E.	  C.,	  Kremer,	  Y.,	  Lefort,	  S.,	  Harada,	  M.,	  Pascoli,	  V.,	  Rohner,	  C.,	  &	  Luscher,	  C.	  
(2015).	  Accumbal	  D1R	  Neurons	  Projecting	  to	  Lateral	  Hypothalamus	  
Authorize	  Feeding.	  Neuron,	  88(3),	  553-­‐564.	  
doi:10.1016/j.neuron.2015.09.038	  
Orozco,	  L.	  (2014).	  Use	  Synchronous	  Detection	  to	  Make	  Precision,	  Low	  Level	  
Measurements.	  Analog	  Devices,	  1-­‐8.	  	  
Pagoto,	  S.	  L.	  P.,	  L.;	  	  Emmons,	  K.	  .	  (2012).	  Policy	  Brief:	  The	  Soceity	  of	  Behavioral	  
Medicine	  position	  statement	  on	  the	  CMS	  decision	  memo	  on	  intensive	  
behavior	  therapy	  for	  obesity.	  Translational	  Behavioral	  Medicine.	  	  
Pandit,	  R.,	  la	  Fleur,	  S.	  E.,	  &	  Adan,	  R.	  A.	  (2013).	  The	  role	  of	  melanocortins	  and	  
Neuropeptide	  Y	  in	  food	  reward.	  Eur	  J	  Pharmacol.	  
doi:10.1016/j.ejphar.2013.04.059	  
Pedram,	  P.,	  Wadden,	  D.,	  Amini,	  P.,	  Gulliver,	  W.,	  Randell,	  E.,	  Cahill,	  F.,	  .	  .	  .	  Sun,	  G.	  
(2013).	  Food	  addiction:	  its	  prevalence	  and	  significant	  association	  with	  
obesity	  in	  the	  general	  population.	  PLoS	  One,	  8(9),	  e74832.	  
doi:10.1371/journal.pone.0074832	  
Perri,	  M.	  G.	  (2014).	  Effects	  of	  behavioral	  treatment	  on	  long-­‐term	  weight	  loss:	  lessons	  
learned	  from	  the	  look	  AHEAD	  trial.	  Obesity	  (Silver	  Spring),	  22(1),	  3-­‐4.	  
doi:10.1002/oby.20672	  
Ryan,	  D.	  H.,	  Espeland,	  M.	  A.,	  Foster,	  G.	  D.,	  Haffner,	  S.	  M.,	  Hubbard,	  V.	  S.,	  Johnson,	  K.	  
C.,	  .	  .	  .	  Look,	  A.	  R.	  G.	  (2003).	  Look	  AHEAD	  (Action	  for	  Health	  in	  Diabetes):	  
	   45	  
design	  and	  methods	  for	  a	  clinical	  trial	  of	  weight	  loss	  for	  the	  prevention	  of	  
cardiovascular	  disease	  in	  type	  2	  diabetes.	  Control	  Clin	  Trials,	  24(5),	  610-­‐628.	  	  
Services,	  C.	  f.	  M.	  a.	  M.	  (2011).	  Decision	  memo	  for	  intensive	  behavioral	  therapy	  for	  
obesity.	  	  
Soares-­‐Cunha,	  C.,	  Coimbra,	  B.,	  David-­‐Pereira,	  A.,	  Borges,	  S.,	  Pinto,	  L.,	  Costa,	  P.,	  .	  .	  .	  
Rodrigues,	  A.	  J.	  (2016).	  Activation	  of	  D2	  dopamine	  receptor-­‐expressing	  
neurons	  in	  the	  nucleus	  accumbens	  increases	  motivation.	  Nat	  Commun,	  7,	  
11829.	  doi:10.1038/ncomms11829	  
Spivak,	  H.,	  Abdelmelek,	  M.	  F.,	  Beltran,	  O.	  R.,	  Ng,	  A.	  W.,	  &	  Kitahama,	  S.	  (2012).	  Long-­‐
term	  outcomes	  of	  laparoscopic	  adjustable	  gastric	  banding	  and	  laparoscopic	  
Roux-­‐en-­‐Y	  gastric	  bypass	  in	  the	  United	  States.	  Surg	  Endosc,	  26(7),	  1909-­‐1919.	  
doi:10.1007/s00464-­‐011-­‐2125-­‐z	  
Stratford,	  T.	  R.,	  &	  Kelley,	  A.	  E.	  (1997).	  GABA	  in	  the	  nucleus	  accumbens	  shell	  
participates	  in	  the	  central	  regulation	  of	  feeding	  behavior.	  J	  Neurosci,	  17(11),	  
4434-­‐4440.	  	  
Stratford,	  T.	  R.,	  &	  Kelley,	  A.	  E.	  (1999).	  Evidence	  of	  a	  functional	  relationship	  between	  
the	  nucleus	  accumbens	  shell	  and	  lateral	  hypothalamus	  subserving	  the	  
control	  of	  feeding	  behavior.	  J	  Neurosci,	  19(24),	  11040-­‐11048.	  	  
Stratford,	  T.	  R.,	  Swanson,	  C.	  J.,	  &	  Kelley,	  A.	  (1998).	  Specific	  changes	  in	  food	  intake	  
elicited	  by	  blockade	  or	  activation	  of	  glutamate	  receptors	  in	  the	  nucleus	  
accumbens	  shell.	  Behav	  Brain	  Res,	  93(1-­‐2),	  43-­‐50.	  	  
Taha,	  S.	  A.,	  &	  Fields,	  H.	  L.	  (2005).	  Encoding	  of	  palatability	  and	  appetitive	  behaviors	  
by	  distinct	  neuronal	  populations	  in	  the	  nucleus	  accumbens.	  J	  Neurosci,	  25(5),	  
1193-­‐1202.	  doi:10.1523/JNEUROSCI.3975-­‐04.2005	  
Taha,	  S.	  A.,	  &	  Fields,	  H.	  L.	  (2006).	  Inhibitions	  of	  nucleus	  accumbens	  neurons	  encode	  
a	  gating	  signal	  for	  reward-­‐directed	  behavior.	  J	  Neurosci,	  26(1),	  217-­‐222.	  
doi:10.1523/JNEUROSCI.3227-­‐05.2006	  
Tate,	  D.	  F.,	  &	  Wing,	  R.	  R.	  (2000).	  Behavior	  Modification	  for	  Obesity.	  In	  L.	  J.	  De	  Groot,	  
G.	  Chrousos,	  K.	  Dungan,	  K.	  R.	  Feingold,	  A.	  Grossman,	  J.	  M.	  Hershman,	  C.	  Koch,	  
M.	  Korbonits,	  R.	  McLachlan,	  M.	  New,	  J.	  Purnell,	  R.	  Rebar,	  F.	  Singer,	  &	  A.	  Vinik	  
(Eds.),	  Endotext.	  South	  Dartmouth	  (MA).	  
van	  den	  Heuvel,	  J.	  K.,	  Furman,	  K.,	  Gumbs,	  M.	  C.,	  Eggels,	  L.,	  Opland,	  D.	  M.,	  Land,	  B.	  B.,	  .	  .	  .	  
la	  Fleur,	  S.	  E.	  (2015).	  Neuropeptide	  Y	  activity	  in	  the	  nucleus	  accumbens	  
modulates	  feeding	  behavior	  and	  neuronal	  activity.	  Biol	  Psychiatry,	  77(7),	  
633-­‐641.	  doi:10.1016/j.biopsych.2014.06.008	  
Volkow,	  N.	  D.,	  Fowler,	  J.	  S.,	  Wang,	  G.	  J.,	  &	  Swanson,	  J.	  M.	  (2004).	  Dopamine	  in	  drug	  
abuse	  and	  addiction:	  results	  from	  imaging	  studies	  and	  treatment	  
implications.	  Mol	  Psychiatry,	  9(6),	  557-­‐569.	  doi:10.1038/sj.mp.4001507	  
Wadden,	  T.	  A.,	  &	  Butryn,	  M.	  L.	  (2003).	  Behavioral	  treatment	  of	  obesity.	  Endocrinol	  
Metab	  Clin	  North	  Am,	  32(4),	  981-­‐1003,	  x.	  	  
Wadden,	  T.	  A.,	  McGuckin,	  B.	  G.,	  Rothman,	  R.	  A.,	  &	  Sargent,	  S.	  L.	  (2003).	  Lifestyle	  
modification	  in	  the	  management	  of	  obesity.	  J	  Gastrointest	  Surg,	  7(4),	  452-­‐463.	  	  
Wang,	  G.	  J.,	  Geliebter,	  A.,	  Volkow,	  N.	  D.,	  Telang,	  F.	  W.,	  Logan,	  J.,	  Jayne,	  M.	  C.,	  .	  .	  .	  Fowler,	  
J.	  S.	  (2011).	  Enhanced	  striatal	  dopamine	  release	  during	  food	  stimulation	  in	  
binge	  eating	  disorder.	  Obesity	  (Silver	  Spring),	  19(8),	  1601-­‐1608.	  
doi:10.1038/oby.2011.27	  
	   46	  
Wang,	  G.	  J.,	  Volkow,	  N.	  D.,	  Logan,	  J.,	  Pappas,	  N.	  R.,	  Wong,	  C.	  T.,	  Zhu,	  W.,	  .	  .	  .	  Fowler,	  J.	  S.	  
(2001).	  Brain	  dopamine	  and	  obesity.	  Lancet,	  357(9253),	  354-­‐357.	  	  
Wang,	  G.	  J.,	  Volkow,	  N.	  D.,	  Thanos,	  P.	  K.,	  &	  Fowler,	  J.	  S.	  (2004).	  Similarity	  between	  
obesity	  and	  drug	  addiction	  as	  assessed	  by	  neurofunctional	  imaging:	  a	  
concept	  review.	  J	  Addict	  Dis,	  23(3),	  39-­‐53.	  doi:10.1300/J069v23n03_04	  
Wickens,	  J.	  R.,	  Budd,	  C.	  S.,	  Hyland,	  B.	  I.,	  &	  Arbuthnott,	  G.	  W.	  (2007).	  Striatal	  
contributions	  to	  reward	  and	  decision	  making:	  making	  sense	  of	  regional	  
variations	  in	  a	  reiterated	  processing	  matrix.	  Ann	  N	  Y	  Acad	  Sci,	  1104,	  192-­‐212.	  
doi:10.1196/annals.1390.016	  
Willuhn,	  I.,	  Wanat,	  M.	  J.,	  Clark,	  J.	  J.,	  &	  Phillips,	  P.	  E.	  (2010).	  Dopamine	  signaling	  in	  the	  
nucleus	  accumbens	  of	  animals	  self-­‐administering	  drugs	  of	  abuse.	  Curr	  Top	  
Behav	  Neurosci,	  3,	  29-­‐71.	  doi:10.1007/7854_2009_27	  
Wing,	  R.	  R.,	  &	  Phelan,	  S.	  (2005).	  Long-­‐term	  weight	  loss	  maintenance.	  Am	  J	  Clin	  Nutr,	  
82(1	  Suppl),	  222S-­‐225S.	  	  
7 	  
